Not applicableLooking for participantsNCT03726359What this trial is testingPhase I Study of Fractionated Stereotactic Radiation TherapyWho this might be right forBrain Metastases Albert Einstein College of Medicine 43
Early research (Phase 1)Looking for participantsNCT06873659What this trial is testingSON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorGastric CancerLiver Cancer Qurgen Inc. 96
Large-scale testing (Phase 3)UnknownNCT03500380What this trial is testingRC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver MetastasesWho this might be right forBreast NeoplasmsBreast DiseasesCapecitabine+3 more RemeGen Co., Ltd. 301
Not applicableStudy completedNCT02547480What this trial is testingLifePearl-Iri Pharmacokinetic StudyWho this might be right forMetastatic Colorectal CancermCRC Terumo Europe N.V. 15
Testing effectiveness (Phase 2)Study completedNCT04300790What this trial is testingStudy to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC PatientsWho this might be right forBreast Cancer MedSIR 69
Testing effectiveness (Phase 2)Study completedNCT03609424What this trial is testingPDR001 Plus Imatinib for Metastatic or Unresectable GISTWho this might be right forGastrointestinal Stromal Tumors Asan Medical Center 39
Not applicableWithdrawnNCT02168179What this trial is testingKeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast CancerWho this might be right forDuctal Breast Carcinoma in SituSkin Reactions Secondary to Radiation TherapyStage IA Breast Cancer+4 more Wake Forest University Health Sciences
Testing effectiveness (Phase 2)WithdrawnNCT01479179What this trial is testingTrastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on TrastuzumabWho this might be right forBreast Cancer M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01887288What this trial is testingCapecitabine With Digoxin for Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Western Regional Medical Center 16
Testing effectiveness (Phase 2)Study completedNCT01266603What this trial is testingHigh-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCIWho this might be right forMelanoma M.D. Anderson Cancer Center 44
Testing effectiveness (Phase 2)Study completedNCT00045227What this trial is testingVaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate CancerWho this might be right forProstate Cancer National Cancer Institute (NCI)
Large-scale testing (Phase 3)Not Yet RecruitingNCT07822542What this trial is testingA Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as First-Line Therapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Jiangsu Hansoh Pharmaceutical Co., Ltd. 448
Early research (Phase 1)Study completedNCT03324373What this trial is testingLenvatinib and Everolimus in Renal Cell Carcinoma (RCC)Who this might be right forRenal Cell Carcinoma Yousef Zakharia 11
Early research (Phase 1)Study completedNCT04750473What this trial is testingFluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Invasive Breast Lobular CarcinomaMetastatic Breast Lobular Carcinoma+1 more Emory University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07767474What this trial is testingEvaluate ATX-898 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Antares Therapeutics, Inc 343
Early research (Phase 1)Study completedNCT00003713What this trial is testingChemotherapy in Treating Patients With Advanced or Metastatic Solid TumorsWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific Genzyme, a Sanofi Company 35
Testing effectiveness (Phase 2)Study completedNCT00248560What this trial is testingGemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer Barbara Ann Karmanos Cancer Institute 36
Testing effectiveness (Phase 2)Study completedNCT00083720What this trial is testingErbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to ChemotherapyWho this might be right forColorectal NeoplasmsMetastasesNeoplasm Eli Lilly and Company 87
Early research (Phase 1)Ended earlyNCT02487823What this trial is testingDose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate CancerWho this might be right forNon Castrate Metastatic Prostate Cancer Institut Paoli-Calmettes 6
Not applicableStudy completedNCT00970359What this trial is testingReacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244Who this might be right forThyroid Cancer Memorial Sloan Kettering Cancer Center 24